Aull & Monroe Investment Management Corp - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.

Quarter-by-quarter ownership
Aull & Monroe Investment Management Corp ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$442,174
+0.2%
4,341
-0.8%
0.23%
+4.1%
Q2 2023$441,481
+9.7%
4,3750.0%0.22%
+8.3%
Q1 2023$402,500
+1.4%
4,3750.0%0.20%
+3.5%
Q4 2022$396,900
+19.2%
4,3750.0%0.20%
+8.8%
Q3 2022$333,000
-10.0%
4,3750.0%0.18%
-2.7%
Q2 2022$370,000
-4.6%
4,375
-1.1%
0.19%
+6.9%
Q1 2022$388,000
+0.3%
4,4250.0%0.18%
+1.7%
Q4 2021$387,000
+9.3%
4,425
+2.3%
0.17%
-1.1%
Q3 2021$354,000
-10.4%
4,3250.0%0.17%
-7.4%
Q2 2021$395,000
+6.8%
4,3250.0%0.19%
+4.4%
Q1 2021$370,000
-12.5%
4,325
-3.4%
0.18%
-20.0%
Q4 2020$423,000
+8.7%
4,4750.0%0.22%
-1.3%
Q3 2020$389,000
-4.7%
4,475
-4.3%
0.23%
-9.5%
Q2 2020$408,000
+7.1%
4,675
+1.1%
0.25%
-1.6%
Q1 2020$381,000
-16.6%
4,625
-4.1%
0.26%
+10.3%
Q4 2019$457,000
+9.1%
4,8250.0%0.23%
+4.5%
Q3 2019$419,000
-11.4%
4,825
-2.0%
0.22%
-12.3%
Q1 2019$473,000
+4.4%
4,925
-6.6%
0.25%
-2.3%
Q4 2018$453,000
-5.6%
5,275
-5.4%
0.26%
+12.1%
Q3 2018$480,000
+16.2%
5,575
+1.8%
0.23%
+9.0%
Q2 2018$413,000
-10.0%
5,475
-3.5%
0.21%
-11.3%
Q1 2018$459,000
-0.2%
5,675
+3.7%
0.24%
+3.0%
Q4 2017$460,000
-2.1%
5,4750.0%0.23%
-4.1%
Q3 2017$470,000
+2.8%
5,4750.0%0.24%
-0.8%
Q2 2017$457,000
+9.3%
5,475
-2.7%
0.24%
+9.4%
Q1 2017$418,000
+2.0%
5,6250.0%0.22%
-3.0%
Q4 2016$410,000
-7.7%
5,6250.0%0.23%
-9.8%
Q3 2016$444,000
-4.5%
5,6250.0%0.26%
-4.9%
Q2 2016$465,000
+11.5%
5,625
-2.4%
0.27%
+7.2%
Q1 2016$417,000
-15.6%
5,762
+0.3%
0.25%
-18.3%
Q4 2015$494,000
-6.3%
5,7420.0%0.31%
-10.3%
Q3 2015$527,000
-12.0%
5,742
-0.6%
0.34%
-3.1%
Q2 2015$599,000
-0.5%
5,776
-5.3%
0.35%
+4.1%
Q1 2015$602,000
+3.1%
6,098
-3.2%
0.34%
+6.6%
Q4 2014$584,000
-6.7%
6,298
-5.3%
0.32%
-4.5%
Q3 2014$626,000
+5.6%
6,648
+1.5%
0.33%
+4.7%
Q2 2014$593,000
+6.5%
6,5500.0%0.32%
-0.3%
Q1 2014$557,000
+4.3%
6,550
-1.5%
0.32%
+1.9%
Q4 2013$534,000
-99.9%
6,6500.0%0.31%
-5.7%
Q3 2013$510,122,000
+109840.1%
6,650
+1.5%
0.33%
+6.1%
Q2 2013$464,0006,5500.31%
Other shareholders
NOVARTIS A G shareholders Q2 2020
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders